Crystal Roger insider trades
Crystal Roger has filed 15 Form 4s with the SEC that we hold, for OPNT (Chief Executive Officer, Director, 10% owner) and Definium Therapeutics, Inc. (DFTX) (Director). Across all of them we count 1 purchase worth $2.3K and 6 sales worth $262.4K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,029 shares of OPNT worth $101.6K, dated 2023-01-05. The first filing on our record is dated 2021-09-16 and the latest 2026-06-15.
OPNT
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-16 | P, purchase reported on Form 4 | 100 | $2.3K | 2021-09-16 |
| 2022-01-10 | S, sale reported on Form 4 | 1,058 | $32.3K | 2022-01-12 |
| 2022-01-27 | S, sale reported on Form 4 | 1,995 | $52.2K | 2022-01-27 |
| 2022-07-14 | S, sale reported on Form 4 | 2,246 | $25.0K | 2022-07-15 |
| 2023-01-05 | S, sale reported on Form 4 | 5,029 | $101.6K | 2023-01-05 |
| 2023-01-09 | S, sale reported on Form 4 | 1,183 | $23.9K | 2023-01-09 |
| 2023-01-27 | S, sale reported on Form 4 | 1,358 | $27.5K | 2023-01-31 |
Definium Therapeutics, Inc. (DFTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1656633) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms